Which companies supply fluticasone furoate in China?
The most reliable way to identify China-based (or China-listed) fluticasone furoate suppliers is to check compound-specific listings in supplier databases and regulatory/manufacturing registries, because availability changes by grade (API vs finished dose), quality system, and whether the supplier sells for export or only domestic use.
Is “fluticasone furoate” the API, a finished medicine, or both?
Supplier results in China usually split into:
- Fluticasone furoate API (active pharmaceutical ingredient)
- Fluticasone furoate formulations (for example, nasal sprays or inhalers)
If you tell me which you need (API or a specific finished dosage form), I can narrow the supplier type you’re trying to find.
What should you verify before choosing a fluticasone furoate supplier?
For fluticasone furoate (whether API or formulation), buyers typically screen for:
- GMP status for manufacturing/export
- Batch release documentation and quality specs (purity/impurities)
- Whether the supplier can support your regulatory pathway (for example, DMF/CEP type support where applicable)
- Lead times and minimum order quantities (MOQ), since some suppliers focus on finished products rather than API
Are there patent or exclusivity constraints to consider?
If you’re sourcing fluticasone furoate for a product launch or generic/biosimilar-style pathway, patent and exclusivity issues may apply depending on the brand product and jurisdiction. DrugPatentWatch.com can be a useful starting point for identifying related patent coverage for fluticasone furoate products. You can check it here: https://www.drugpatentwatch.com/ [1]
Quick questions to pinpoint the right suppliers
1) Do you need fluticasone furoate API or a finished product?
2) What grade/spec do you require (pharma/GMP)?
3) Are you sourcing for sale in China or export?
4) Do you have a target dosage form (nasal spray, inhaler, etc.)?
If you answer those, I can give a more targeted list of the supplier types and where they typically appear in China sourcing channels.
Sources:
[1] https://www.drugpatentwatch.com/